Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-29

Clinical Trial Update: Convalescent Plasma for the Treatment of Patients With WNV - a Double- Blind Randomized Controlled Study [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating convalescent plasma for West Nile virus infection with and without neurologic involvement has completed. The provided data i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Sheba Medical Center | Conditions: West Nile Fever With Neurologic Manifestation (Diagnosis), West Nile Fever Without Complications | Phase 3 | Status: COMPLETED